CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
Clinical trial NCT02401815 · COMPLETED
Trial details
- NCT number
- NCT02401815
- Sponsor
- Cogent Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-06
- Primary completion
- 2020-05-11
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.